Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPP4R2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | SERPINI1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | ELK4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | PNPLA2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | GIPC2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | C10orf142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | CSF1R | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | PTPN7 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
mRNA | SMPDL3A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | CAMSAP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |